Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/508"
| Predicate | Value (sorted: none) |
|---|---|
| rdf:type | |
| rdf:type | |
| rdfs:label | |
| ?:Evidence_type | |
| ?:Evidence_dose | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_value | |
| dc:creator | |
| dc:date |
"09/28/2007 13:37:55"
|
| ?:content |
"NOTE: This value is for the extended release formulation. Table 1 of the drug label lists PK parameters for lovastatin and "lovastatin acid" (beta-hydroxy-lovastatin) for both the immediate and extended release forms.
Lovastatin (immediate release):5.5ng/ml
Lovastatin (extended release):7.8ng/ml
Lovastatin acid (immediate release):5.8ng/ml
Lovastatin acid (extended release):11.9ng/ml"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ beta-hydroxy-lovastatin_maximum_concentration_continuous_value, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1409 }